Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: The results of the TARHEEL study

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number4
DOIs
StatePublished - Jan 1 2004

Fingerprint

Stavudine
Zidovudine
Highly Active Antiretroviral Therapy
HIV
abacavir

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{fa4d906ced03430c9a3007c95f5171f5,
title = "Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: The results of the TARHEEL study",
author = "John Bartlett",
year = "2004",
month = "1",
day = "1",
doi = "10.1097/01.idc.0000130889.35482.ee",
language = "English (US)",
volume = "12",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine

T2 - The results of the TARHEEL study

AU - Bartlett, John

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026137152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026137152&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000130889.35482.ee

DO - 10.1097/01.idc.0000130889.35482.ee

M3 - Article

AN - SCOPUS:85026137152

VL - 12

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 4

ER -